The DOI matches its Crossref record; 185 of the 185 references it cites were found in a registry or an index.
Recent Advances in Nanoparticle-Based Cancer Drug and Gene Delivery
Open accessAbstract
Effective and safe delivery of anticancer agents is among the major challenges in cancer therapy. The majority of anticancer agents are toxic to normal cells, have poor bioavailability, and lack in vivo stability. Recent advancements in nanotechnology provide safe and efficient drug delivery systems for successful delivery of anticancer agents via nanoparticles. The physicochemical and functional properties of the nanoparticle vary for each of these anticancer agents, including chemotherapeutics, nucleic acid-based therapeutics, small molecule inhibitors, and photodynamic agents. The characteristics of the anticancer agents influence the design and development of nanoparticle carriers. This review focuses on strategies of nanoparticle-based drug delivery for various anticancer agents. Recent advancements in the field are also highlighted, with suitable examples from our own research efforts and from the literature.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans
Fire, A., Xu, S., Montgomery, M. K., Kostas, S. A., Driver, S. E., & Mello, C. C. (1998) · Nature · doi:10.1038/35888 · Cited by 15,429
Molecular properties that influence the oral bioavailability of drug candidates
Veber, D. F., Johnson, S. R., Cheng, H.-Y., Smith, B. R., Ward, K. W., & Kopple, K. D. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020017n · Cited by 8,420
Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
Alvarez-Erviti, L., Seow, Y., Yin, H., Betts, C., Lakhal, S., & Wood, M. J. A. (2011) · Nature Biotechnology · doi:10.1038/nbt.1807 · Cited by 4,930 · cited 1×
“Since exosomes can pass through the stringent blood–brain barrier, exosome-based siRNA delivery for genes involved in brain cancer could be successful in the future (Alvarez-Erviti et al., 2011).”
BackgroundSolid lipid nanoparticles (SLN) for controlled drug delivery â a review of the state of the art
Müller, R. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00087-4 · Cited by 3,759
Biodegradable nanoparticles for drug and gene delivery to cells and tissue
Panyam, J., & Labhasetwar, V. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00228-4 · Cited by 3,361
Monks, A., Scudiero, D., Skehan, P., Shoemaker, R., Paull, K., Vistica, D., Hose, C., Langley, J., Cronise, P., Vaigro-Wolff, A., et al. (1991) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/83.11.757 · Cited by 3,289
Nanoparticle-based targeted drug delivery
Singh, R., & Lillard, J. W. (2009) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2008.12.004 · Cited by 2,734
Zamore, P. D., Tuschl, T., Sharp, P. A., & Bartel, D. P. (2000) · Cell · doi:10.1016/s0092-8674(00)80620-0 · Cited by 2,676
Nanoparticle and targeted systems for cancer therapy
Brannon-Peppas, L., & Blanchette, J. O. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.02.014 · Cited by 2,334
Nicholson, R. I., Gee, J. M. W., & Harper, M. E. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00231-3 · Cited by 2,143
Castano, A. P., Demidova, T. N., & Hamblin, M. R. (2004) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/s1572-1000(05)00007-4 · Cited by 2,052
Small-molecule inhibitors of protein–protein interactions: progressing towards the dream
Arkin, M. R., & Wells, J. A. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1343 · Cited by 1,705 · cited 1×
“Once the inhibitor enters the cells, it affects various other molecules, such as proteins, and ultimately kills cancer cells (Arkin & Wells, 2004).”
BackgroundMagnetic nanomaterials for hyperthermia-based therapy and controlled drug delivery
Kumar, C. S. S. R., & Mohammad, F. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.03.008 · Cited by 1,666
Dicer is essential for mouse development
Bernstein, E., Kim, S. Y., Carmell, M. A., Murchison, E. P., Alcorn, H., Li, M. Z., Mills, A. A., Elledge, S. J., Anderson, K. V., & Hannon, G. J. (2003) · Nature Genetics · doi:10.1038/ng1253 · Cited by 1,627
Acidity Generated by the Tumor Microenvironment Drives Local Invasion
Estrella, V., Chen, T., Lloyd, M., Wojtkowiak, J., Cornnell, H. H., Ibrahim-Hashim, A., Bailey, K., Balagurunathan, Y., Rothberg, J. M., Sloane, B. F., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2796 · Cited by 1,397
Fu, Y., & Kao, W. J. (2010) · Expert Opinion on Drug Delivery · doi:10.1517/17425241003602259 · Cited by 1,305
Dendrimers: synthesis, applications, and properties
Abbasi, E., Aval, S. F., Akbarzadeh, A., Milani, M., Nasrabadi, H. T., Joo, S. W., Hanifehpour, Y., Nejati-Koshki, K., & Pashaei-Asl, R. (2014) · Nanoscale Research Letters · doi:10.1186/1556-276x-9-247 · Cited by 1,279
Parker, N., Turk, M. J., Westrick, E., Lewis, J. D., Low, P. S., & Leamon, C. P. (2005) · Analytical Biochemistry · doi:10.1016/j.ab.2004.12.026 · Cited by 1,197
Nanoparticles in photodynamic therapy: An emerging paradigm
Chatterjee, D. K., Fong, L. S., & Zhang, Y. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.08.003 · Cited by 1,184
Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect
Maeda, H., Bharate, G. Y., & Daruwalla, J. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.11.010 · Cited by 1,168
Tissue-Penetrating Delivery of Compounds and Nanoparticles into Tumors
Sugahara, K. N., Teesalu, T., Karmali, P. P., Kotamraju, V. R., Agemy, L., Girard, O. M., Hanahan, D., Mattrey, R. F., & Ruoslahti, E. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.10.013 · Cited by 1,136
Folate and DNA Methylation: A Review of Molecular Mechanisms and the Evidence for Folate's Role
Crider, K. S., Yang, T. P., Berry, R. J., & Bailey, L. B. (2012) · Advances in Nutrition · doi:10.3945/an.111.000992 · Cited by 1,015
Giri, S., Trewyn, B. G., Stellmaker, M. P., & Lin, V. S. ‐. (2005) · Angewandte Chemie International Edition · doi:10.1002/anie.200501819 · Cited by 997
DUFES, C., UCHEGBU, I., & SCHATZLEIN, A. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.09.017 · Cited by 984
Polyethylenimine-based non-viral gene delivery systems
Lungwitz, U., Breunig, M., Blunk, T., & Göpferich, A. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.11.011 · Cited by 983
Okayama, H., Kohno, T., Ishii, Y., Shimada, Y., Shiraishi, K., Iwakawa, R., Furuta, K., Tsuta, K., Shibata, T., Yamamoto, S., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-1403 · Cited by 874
Applications of gold nanoparticles in cancer nanotechnology
Cai, W. (2008) · Nanotechnology, Science and Applications · doi:10.2147/nsa.s3788 · Cited by 851
Wang, C., Tao, H., Cheng, L., & Liu, Z. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.05.007 · Cited by 824
Mesoporous silica nanoparticles in target drug delivery system: A review
Bharti, C., Gulati, N., Nagaich, U., & Pal, A. (2015) · International Journal of Pharmaceutical Investigation · doi:10.4103/2230-973x.160844 · Cited by 817
The transferrin receptor and the targeted delivery of therapeutic agents against cancer
Daniels, T. R., Bernabeu, E., Rodríguez, J. A., Patel, S., Kozman, M., Chiappetta, D. A., Holler, E., Ljubimova, J. Y., Helguera, G., & Penichet, M. L. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2011.07.016 · Cited by 807
Delivery of siRNA Therapeutics: Barriers and Carriers
Wang, J., Lu, Z., Wientjes, M. G., & Au, J. L.-S. (2010) · The AAPS Journal · doi:10.1208/s12248-010-9210-4 · Cited by 798
Nanoparticles for drug delivery in cancer treatment
Haley, B., & Frenkel, E. (2008) · Urologic Oncology: Seminars and Original Investigations · doi:10.1016/j.urolonc.2007.03.015 · Cited by 791
Enzyme-responsive nanoparticles for drug release and diagnostics
de la Rica, R., Aili, D., & Stevens, M. M. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.01.002 · Cited by 765
Magnetic nanoparticles for gene and drug delivery
Dobson (2008) · International Journal of Nanomedicine · doi:10.2147/ijn.s1608 · Cited by 755
Johnsen, K. B., Gudbergsson, J. M., Skov, M. N., Pilgaard, L., Moos, T., & Duroux, M. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.04.005 · Cited by 704
Dendrimers in drug delivery and targeting: Drug-dendrimer interactions and toxicity issues
Pandita, D., Madaan, K., Kumar, S., Poonia, N., & Lather, V. (2014) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/0975-7406.130965 · Cited by 679
Therapeutic EphA2 Gene Targeting In vivo Using Neutral Liposomal Small Interfering RNA Delivery
Landen, C. N., Chavez-Reyes, A., Bucana, C., Schmandt, R., Deavers, M. T., Lopez-Berestein, G., & Sood, A. K. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0530 · Cited by 675
Enzyme-responsive nanomaterials for controlled drug delivery
Hu, Q., Katti, P. S., & Gu, Z. (2014) · Nanoscale · doi:10.1039/c4nr04249b · Cited by 668
Greish, K. (2007) · Journal of Drug Targeting · doi:10.1080/10611860701539584 · Cited by 600
Dumontet, C., & Sikic, B. I. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.3.1061 · Cited by 574
Nanotechnology-based combinational drug delivery: an emerging approach for cancer therapy
Parhi, P., Mohanty, C., & Sahoo, S. K. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.05.010 · Cited by 573
Light‐sensitive Intelligent Drug Delivery Systems†
Alvarez‐Lorenzo, C., Bromberg, L., & Concheiro, A. (2009) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.2008.00530.x · Cited by 519
Deng, X., Cao, M., Zhang, J., Hu, K., Yin, Z., Zhou, Z., Xiao, X., Yang, Y., Sheng, W., Wu, Y., et al. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.02.006 · Cited by 511
Photochemical mechanisms of light-triggered release from nanocarriers
Fomina, N., Sankaranarayanan, J., & Almutairi, A. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.02.006 · Cited by 491
Silencing disease genes in the laboratory and the clinic
Watts, J. K., & Corey, D. R. (2012) · The Journal of Pathology · doi:10.1002/path.2993 · Cited by 470
Gene Therapy for Cancer Treatment: Past, Present and Future
Cross, D., & Burmester, J. K. (2006) · Clinical Medicine & Research · doi:10.3121/cmr.4.3.218 · Cited by 455
Miura, Y., Takenaka, T., Toh, K., Wu, S., Nishihara, H., Kano, M. R., Ino, Y., Nomoto, T., Matsumoto, Y., Koyama, H., et al. (2013) · ACS Nano · doi:10.1021/nn402662d · Cited by 454
Liposomes for use in gene delivery
Balazs, D. A., & Godbey, W. (2011) · Journal of Drug Delivery · doi:10.1155/2011/326497 · Cited by 441
siRNA Delivery Strategies: A Comprehensive Review of Recent Developments
Tatiparti, K., Sau, S., Kashaw, S., & Iyer, A. (2017) · Nanomaterials · doi:10.3390/nano7040077 · Cited by 429
Taratula, O., Kuzmov, A., Shah, M., Garbuzenko, O. B., & Minko, T. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.04.018 · Cited by 416
Pencheva, N., Tran, H., Buss, C., Huh, D., Drobnjak, M., Busam, K., & Tavazoie, S. F. (2012) · Cell · doi:10.1016/j.cell.2012.10.028 · Cited by 415 · cited 1×
“Another approach to achieve synergistic therapeutic response is to use multiple miRNAs involved in a critical pathway (Pencheva et al., 2012).”
BackgroundPrabaharan, M., Grailer, J. J., Pilla, S., Steeber, D. A., & Gong, S. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.07.020 · Cited by 377
A new era of cancer treatment: carbon nanotubes as drug delivery tools
Seifalian, A. (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s16923 · Cited by 366
Chemical modification of siRNAs to improve serum stability without loss of efficacy
Choung, S., Kim, Y. J., Kim, S., Park, H.-O., & Choi, Y.-C. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.02.049 · Cited by 348
Thermosensitive liposomal drug delivery systems: state of the art review
Hossann, M., Kneidl, B., Peller, M., Lindner, L., & Winter, G. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s49297 · Cited by 342
Sahoo, S. K., Ma, W., & Labhasetwar, V. (2004) · International Journal of Cancer · doi:10.1002/ijc.20405 · Cited by 327
Exosomes as novel bio-carriers for gene and drug delivery
Jiang, X.-C., & Gao, J.-Q. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.02.038 · Cited by 321
Cationic liposomes for gene delivery
Simões, S., Filipe, A., Faneca, H., Mano, M., Penacho, N., Düzgünes, N., & Pedroso de Lima, M. (2005) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2.2.237 · Cited by 285
Recognizing and exploiting differences between RNAi and small-molecule inhibitors
Weiss, W. A., Taylor, S. S., & Shokat, K. M. (2007) · Nature Chemical Biology · doi:10.1038/nchembio1207-739 · Cited by 283
Shu, D., Li, H., Shu, Y., Xiong, G., Carson, W. E., Haque, F., Xu, R., & Guo, P. (2015) · ACS Nano · doi:10.1021/acsnano.5b02471 · Cited by 270
Design of Nanoparticle-Based Carriers for Targeted Drug Delivery
Yu, X., Trase, I., Ren, M., Duval, K., Guo, X., & Chen, Z. (2016) · Journal of Nanomaterials · doi:10.1155/2016/1087250 · Cited by 265
Driving delivery vehicles with ultrasound
Ferrara, K. W. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.03.002 · Cited by 250
Zhao, X., Li, F., Li, Y., Wang, H., Ren, H., Chen, J., Nie, G., & Hao, J. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2014.12.028 · Cited by 247
Vankayala, R., Huang, Y., Kalluru, P., Chiang, C., & Hwang, K. C. (2014) · Small · doi:10.1002/smll.201302719 · Cited by 242
Hom, C., Lu, J., Liong, M., Luo, H., Li, Z., Zink, J. I., & Tamanoi, F. (2010) · Small · doi:10.1002/smll.200901966 · Cited by 239
Saad, M., Garbuzenko, O. B., Ber, E., Chandna, P., Khandare, J. J., Pozharov, V. P., & Minko, T. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.05.024 · Cited by 238
Lipidoid-Coated Iron Oxide Nanoparticles for Efficient DNA and siRNA delivery
Jiang, S., Eltoukhy, A. A., Love, K. T., Langer, R., & Anderson, D. G. (2013) · Nano Letters · doi:10.1021/nl304287a · Cited by 236
Thermosensitive polymeric hydrogels as drug delivery systems
Gong, C., Qi, T., Wei, X., Qu, Y., Wu, Q., Luo, F., & Qian, Z. (2012) · Current Medicinal Chemistry · doi:10.2174/0929867311302010009 · Cited by 228
Wang, Y., Yu, L., Han, L., Sha, X., & Fang, X. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.12.033 · Cited by 226
Al-Ahmady, Z. S., Al-Jamal, W. T., Bossche, J. V., Bui, T. T., Drake, A. F., Mason, A. J., & Kostarelos, K. (2012) · ACS Nano · doi:10.1021/nn302148p · Cited by 224
Mechanisms of Chemotherapeutic Drug Resistance in Cancer Therapy—A Quick Review
Liu, F.-S. (2009) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/s1028-4559(09)60296-5 · Cited by 220
Guerrero-Cázares, H., Tzeng, S. Y., Young, N. P., Abutaleb, A. O., Quiñones-Hinojosa, A., & Green, J. J. (2014) · ACS Nano · doi:10.1021/nn501197v · Cited by 220
Aurora kinase inhibitor nanoparticles target tumors with favorable therapeutic index in vivo
Ashton, S., Song, Y. H., Nolan, J., Cadogan, E., Murray, J., Odedra, R., Foster, J., Hall, P. A., Low, S., Taylor, P., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad2355 · Cited by 218
Wen, H.-Y., Dong, H.-Q., Xie, W.-J., Li, Y.-Y., Wang, K., Pauletti, G. M., & Shi, D.-L. (2011) · Chemical Communications · doi:10.1039/c0cc04983b · Cited by 217
Chitosan Mediated Targeted Drug Delivery System: A Review
Patel, M. P., Patel, R. R., & Patel, J. K. (2010) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j3jc7c · Cited by 214
Tagami, T., Foltz, W. D., Ernsting, M. J., Lee, C. M., Tannock, I. F., May, J. P., & Li, S.-D. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.05.029 · Cited by 213
Gliadel Wafers in the Treatment of Malignant Glioma: A Systematic Review
Perry, J., Chambers, A., Spithoff, K., Laperriere, N., & on behalf of the Neuro-Oncology Disease Site Group§ of Cancer Care Ontario’s Program in Evidence-Based Care (2007) · Current Oncology · doi:10.3747/co.2007.147 · Cited by 212
Wang, Z., Qiao, R., Tang, N., Lu, Z., Wang, H., Zhang, Z., Xue, X., Huang, Z., Zhang, S., Zhang, G., et al. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.02.037 · Cited by 212
PLGA/polymeric liposome for targeted drug and gene co-delivery
Wang, H., Zhao, P., Su, W., Wang, S., Liao, Z., Niu, R., & Chang, J. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.07.082 · Cited by 209
Gene and doxorubicin co-delivery system for targeting therapy of glioma
Liu, S., Guo, Y., Huang, R., Li, J., Huang, S., Kuang, Y., Han, L., & Jiang, C. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.03.031 · Cited by 203
Kumar, B., Kulanthaivel, S., Mondal, A., Mishra, S., Banerjee, B., Bhaumik, A., Banerjee, I., & Giri, S. (2017) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2016.10.049 · Cited by 198
Nanosomes carrying doxorubicin exhibit potent anticancer activity against human lung cancer cells
Srivastava, A., Amreddy, N., Babu, A., Panneerselvam, J., Mehta, M., Muralidharan, R., Chen, A., Zhao, Y. D., Razaq, M., Riedinger, N., et al. (2016) · Scientific Reports · doi:10.1038/srep38541 · Cited by 187
Zhang, C., Pan, D., Li, J., Hu, J., Bains, A., Guys, N., Zhu, H., Li, X., Luo, K., Gong, Q., et al. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.02.047 · Cited by 180
Lipid Nanoparticles for Gene Delivery
Zhao, Y., & Huang, L. (2014) · Advances in Genetics · doi:10.1016/b978-0-12-800148-6.00002-x · Cited by 178
Cationic lipid nanoparticles for therapeutic delivery of siRNA and miRNA to murine liver tumor
Hsu, S.-H., Yu, B., Wang, X., Lu, Y., Schmidt, C. R., Lee, R. J., Lee, L. J., Jacob, S. T., & Ghoshal, K. (2013) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2013.05.007 · Cited by 173
Yin, T., Wang, L., Yin, L., Zhou, J., & Huo, M. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.05.022 · Cited by 172
Systemic and Specific Delivery of Small Interfering RNAs to the Liver Mediated by Apolipoprotein A-I
Kim, S. I., Shin, D., Choi, T. H., Lee, J. C., Cheon, G.-J., Kim, K.-Y., Park, M., & Kim, M. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300168 · Cited by 169
Thermo-responsive systems for controlled drug delivery
Bikram, M., & West, J. L. (2008) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.5.10.1077 · Cited by 169
External-stimuli responsive systems for cancer theranostic
Yao, J., Feng, J., & Chen, J. (2016) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2016.06.001 · Cited by 163
Jiang, L., Vader, P., & Schiffelers, R. M. (2017) · Gene Therapy · doi:10.1038/gt.2017.8 · Cited by 162
Thermosensitive Polymeric Hydrogels As Drug Delivery Systems
Gong, C., Qi, T., Wei, X., Qu, Y., Wu, Q., Luo, F., & Qian, Z. (2012) · Current Medicinal Chemistry · doi:10.2174/09298673130109 · Cited by 161
Ultrasound-guided delivery of microRNA loaded nanoparticles into cancer
Wang, T.-Y., Choe, J. W., Pu, K., Devulapally, R., Bachawal, S. V., Machtaler, S., Chowdhury, S. M., Luong, R. H., Tian, L., Khuri-Yakub, B. T., et al. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.02.018 · Cited by 159
Hua, M., Liu, H.-L., Yang, H., Chen, P., Tsai, R., Huang, C.-Y., Tseng, I.-C., Lyu, L.-A., Ma, C.-C., Tang, H.-J., et al. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.09.065 · Cited by 157
Li, F., Li, T., Cao, W., Wang, L., & Xu, H. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.04.032 · Cited by 156
Multifaceted Applications of Chitosan in Cancer Drug Delivery and Therapy
Babu, A., & Ramesh, R. (2017) · Marine Drugs · doi:10.3390/md15040096 · Cited by 154
Synthesis and in Vivo Antitumor Activity of Poly( l -glutamic acid) Conjugates of 20(S)-Camptothecin
Bhatt, R., de Vries, P. W., Tulinsky, J., Bellamy, G., Baker, B., Singer, J. W., & Klein, P. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020022r · Cited by 152
Herman, T. S., Teicher, B. A., Jochelson, M. S., Clark, J., Svensson, G. K., & Coleman, C. N. (1988) · International Journal of Hyperthermia · doi:10.3109/02656738809029305 · Cited by 147
Chen, Q., Xu, M., Zheng, W., Xu, T., Deng, H., & Liu, J. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b12792 · Cited by 147
Novel cationic solid lipid nanoparticles enhanced p53 gene transfer to lung cancer cells
Choi, S. H. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.07.011 · Cited by 146
Cheng, Y., Hao, J., Lee, L. A., Biewer, M. C., Wang, Q., & Stefan, M. C. (2012) · Biomacromolecules · doi:10.1021/bm300823y · Cited by 145
Recent Advances on Inorganic Nanoparticle-Based Cancer Therapeutic Agents
Wang, F., Li, C., Cheng, J., & Yuan, Z. (2016) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph13121182 · Cited by 145
Advanced Materials for Co‐Delivery of Drugs and Genes in Cancer Therapy
Khan, M., Ong, Z. Y., Wiradharma, N., Attia, A. B. E., & Yang, Y. Y. (2012) · Advanced Healthcare Materials · doi:10.1002/adhm.201200109 · Cited by 143
Zhang, L., Wang, T., Yang, L., Liu, C., Wang, C., Liu, H., Wang, Y. A., & Su, Z. (2012) · Chemistry - A European Journal · doi:10.1002/chem.201200030 · Cited by 136
Xie, Y., Kim, N. H., Nadithe, V., Schalk, D. L., Thakur, A. B., Kılıç, A., Lum, L. G., Bassett, D. J. P., & Merkel, O. M. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.03.029 · Cited by 130
Anionic liposomal delivery system for DNA transfection
Patil, S. D., Rhodes, D. G., & Burgess, D. J. (2004) · The AAPS Journal · doi:10.1208/aapsj060429 · Cited by 126
Stimuli-Responsive Molecularly Imprinted Polymers for Drug Delivery: A Review
Puoci, F., Iemma, F., & Picci, N. (2008) · Current Drug Delivery · doi:10.2174/156720108783954888 · Cited by 126
Exosomes: Nanoparticulate tools for RNA interference and drug delivery
Shahabipour, F., Barati, N., Johnston, T. P., Derosa, G., Maffioli, P., & Sahebkar, A. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25766 · Cited by 126
Sabbatini, P. J., Aghajanian, C. A., Dizon, D. S., Anderson, S., Dupont, J., Brown, J. V., Peters, W. A., Jacobs, A. D., Mehdi, A., Rivkin, S. E., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.12.043 · Cited by 125
Ultrasound-induced cavitation: applications in drug and gene delivery
Paliwal, S., & Mitragotri, S. (2006) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.3.6.713 · Cited by 119
Ito, I., Ji, L., Tanaka, F., Saito, Y., Gopalan, B., Branch, C. D., Xu, K., Atkinson, E. N., Bekele, B. N., Stephens, L. C., et al. (2004) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700756 · Cited by 117
A new era of cancer treatment: carbon nanotubes as drug delivery tools
Madani, S. Y., Naderi, N., (17249869), O. D., Tan, A., & Seifalian, A. M. (2024) · Figshare · Cited by 116
The effect of a susceptibility to motion sickness on the side effects of cancer chemotherapy
Morrow, G. R. (1985) · Cancer · doi:10.1002/1097-0142(19850615)55:12<2766::aid-cncr2820551207>3.0.co;2-7 · Cited by 115
Mendes, R. G. P. R., Fernandes, A. R., & Baptista, P. V. (2017) · Genes · doi:10.3390/genes8030094 · Cited by 113
A polyamidoamne dendrimer functionalized graphene oxide for DOX and MMP-9 shRNA plasmid co-delivery
Gu, Y., Guo, Y., Wang, C., Xu, J., Wu, J., Kirk, T. B., Ma, D., & Xue, W. (2016) · Materials Science and Engineering C · doi:10.1016/j.msec.2016.09.035 · Cited by 112
Tumor-targeted pH/redox dual-sensitive unimolecular nanoparticles for efficient siRNA delivery
Chen, G., Wang, Y., Xie, R., & Gong, S. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.01.042 · Cited by 110
Li, H., Wang, P., Deng, Y., Zeng, M., Tang, Y., Zhu, W., & Cheng, Y. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.05.030 · Cited by 110
Cun, X., Chen, J., Ruan, S., Zhang, L., Wan, J., He, Q., & Gao, H. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b09391 · Cited by 109
Deng, L., Li, Q., Al-Rehili, S., Omar, H. W., Almalik, A., Alshamsan, A., Zhang, J., & Khashab, N. M. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b00322 · Cited by 108
Lee, S. J., Yhee, J. Y., Kim, S. H., Kwon, I. C., & Kim, K. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.09.002 · Cited by 107
Yokoyama, T., Tam, J., Kuroda, S., Scott, A. W., Aaron, J., Larson, T., Shanker, M., Correa, A. M., Kondo, S., Roth, J. A., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025507 · Cited by 107
Delivery of siRNA from lyophilized polymeric surfaces
Andersen, M. Ø., Howard, K. A., Paludan, S. R., Besenbacher, F., & Kjems, J. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.10.003 · Cited by 105
Theranostic Multilayer Capsules for Ultrasound Imaging and Guided Drug Delivery
Chen, J., Ratnayaka, S. H., Alford, A., Kozlovskaya, V., Liu, F., Xue, B., Hoyt, K., & Kharlampieva, E. (2017) · ACS Nano · doi:10.1021/acsnano.7b00151 · Cited by 105
α-Amylase- and Redox-Responsive Nanoparticles for Tumor-Targeted Drug Delivery
Li, Y., Hu, H., Zhou, Q., Ao, Y., Xiao, C., Wan, J., Wan, Y., Xu, H., Li, Z., & Yang, X. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b04066 · Cited by 101
Exosomes: A Role for Naturally Occurring Nanovesicles in Cancer Growth, Diagnosis and Treatment
Srivastava, A., Filant, J., Moxley, K. M., Sood, A. K., McMeekin, S., & Ramesh, R. (2015) · Current Gene Therapy · doi:10.2174/1566523214666141224100612 · Cited by 99
Muralidharan, R., Babu, A., Amreddy, N., Basalingappa, K. M., Mehta, M., Chen, A., Zhao, Y. D., Kompella, U. B., Munshi, A., & Ramesh, R. (2016) · Journal of Nanobiotechnology · doi:10.1186/s12951-016-0201-1 · Cited by 99
Exploitation of Exosomes as Nanocarriers for Gene-, Chemo-, and Immune-Therapy of Cancer
Srivastava, A., Babu, A., Filant, J., Moxley, K., Ruskin, R., Dhanasekaran, D. N., Sood, A., McMeekin, S., & Ramesh, R. (2016) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2016.2205 · Cited by 96
Use of Nanotechnology to Develop Multi-Drug Inhibitors for Cancer Therapy
Gowda, R., Jones, N. R., Banerjee, S., & Robertson, G. P. (2013) · Journal of Nanomedicine & Nanotechnology · doi:10.4172/2157-7439.1000184 · Cited by 95
Babu, A., Wang, Q., Muralidharan, R., Shanker, M., Munshi, A., & Ramesh, R. (2014) · Molecular Pharmaceutics · doi:10.1021/mp500259e · Cited by 94
Self-citationThe investigation of polymer-siRNA nanoparticle for gene therapy of gastric cancer in vitro
Wu, W. Y. (2010) · International Journal of Nanomedicine · doi:10.2147/ijn.s8503 · Cited by 94
Cell Penetrating Peptide Conjugated Chitosan for Enhanced Delivery of Nucleic Acid
Layek, B., Lipp, L., & Singh, J. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161226142 · Cited by 91
Applications of Copolymeric Nanoparticles in Drug Delivery Systems
Danafar, H. (2016) · Drug Research · doi:10.1055/s-0042-109865 · Cited by 91
Chenna, V., Hu, C., Pramanik, D., Aftab, B. T., Karikari, C. A., Campbell, N. R., Hong, S., Zhao, M., Rudek, M. A., Khan, S. R., et al. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0341 · Cited by 90
Lee, J. Y., Crake, C., Teo, B. M., Carugo, D., Victor, M. D. S., Seth, A., & Stride, E. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201601246 · Cited by 90
Lee, S. J., Yook, S., Yhee, J. Y., Yoon, H. Y., Kim, M.-G., Ku, S. H., Kim, S. H., Park, J. H., Jeong, J. H., Kwon, I. C., et al. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.08.032 · Cited by 87
Baghbani, F., & Moztarzadeh, F. (2017) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2017.01.051 · Cited by 85
Baghbani, F., Chegeni, M., Moztarzadeh, F., Hadian-Ghazvini, S., & Raz, M. (2016) · Materials Science and Engineering C · doi:10.1016/j.msec.2016.11.107 · Cited by 82
iRGD as a tumor-penetrating peptide for cancer therapy
Yin, H. X., Yang, J., Zhang, Q., Yang, J., Wang, H., Xǔ, J., & Zheng, J. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6419 · Cited by 81
Shi, Q., Fernandes, J., Winnik, F. M., Benderdour, M., Zhang, X., Qiu, & Dai (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s35567 · Cited by 80
Lopes, J., Santos, G., Barata, P., Oliveira, R., & Lopes, C. M. (2013) · Current Pharmaceutical Design · doi:10.2174/13816128113199990698 · Cited by 80
Reduction-Responsive Polymeric Micelles and Vesicles for Triggered Intracellular Drug Release
Sun, H., Meng, F., Cheng, R., Deng, C., & Zhong, Z. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5733 · Cited by 78
Almeida, E. A. M. S., Bellettini, I. C., Garcia, F. P., Farinácio, M. T., Nakamura, C. V., Rubira, A. F., Martins, A. F., & Muniz, E. C. (2017) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2017.05.034 · Cited by 77
Wang, K., Kievit, F. M., Sham, J. G., Jeon, M., Stephen, Z. R., Bakthavatsalam, A., Park, J. O., & Zhang, M. (2015) · Small · doi:10.1002/smll.201501985 · Cited by 75
pH-sensitive Au–BSA–DOX–FA nanocomposites for combined CT imaging and targeted drug delivery
Huang, H., Yang, D., Liu, M., Wang, X., Zhang, Z., Zhou, G., Liu, W., Cao, Y., Zhang, W. J., & Wang, X. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s128270 · Cited by 70
Xu, J., Singh, A., & Amiji, M. M. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-75 · Cited by 68
IL-24 Inhibits Lung Cancer Cell Migration and Invasion by Disrupting The SDF-1/CXCR4 Signaling Axis
Panneerselvam, J., Jin, J., Shanker, M., Lauderdale, J., Bates, J., Wang, Q., Zhao, Y. D., Archibald, S. J., Hubin, T. J., & Ramesh, R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0122439 · Cited by 68
Amoli‐Diva, M., Sadighi‐Bonabi, R., & Pourghazi, K. (2017) · Materials Science and Engineering C · doi:10.1016/j.msec.2017.03.038 · Cited by 68
Reduction- and pH-Sensitive Hyaluronan Nanoparticles for Delivery of Iridium(III) Anticancer Drugs
Cai, Z., Zhang, H., Wei, Y. Z., Wei, Y., Xie, Y., & Cong, F. (2017) · Biomacromolecules · doi:10.1021/acs.biomac.7b00445 · Cited by 68
MPEG–PCL copolymeric nanoparticles in drug delivery systems
Danafar, H. (2016) · Cogent Medicine · doi:10.1080/2331205x.2016.1142411 · Cited by 67
Muralidharan, R., Babu, A., Amreddy, N., Srivastava, A., Chen, A., Zhao, Y. D., Kompella, U. B., Munshi, A., & Ramesh, R. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0134 · Cited by 67
LHRH-targeted nanogels as a delivery system for cisplatin to ovarian cancer
Nukolova, N. V., Oberoi, H. S., Zhao, Y., Chekhonin, V. P., Kabanov, A. V., & Bronich, T. K. (2013) · Molecular Pharmaceutics · doi:10.1021/mp4003688 · Cited by 63
Co-delivery of plasmid DNA and doxorubicin by solid lipid nanoparticles for lung cancer therapy
Han, Y., Zhang, P., Chen, Y., Sun, J., & Kong, F. (2014) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2014.1770 · Cited by 62
Magnetic stimuli-responsive chitosan-based drug delivery biocomposite for multiple triggered release
Harris, M. A., Ahmed, H. M., Barr, B., LeVine, D., Pace, L. R., Mohapatra, A., Morshed, B. I., Bumgardner, J. D., & Jennings, J. A. (2017) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2017.03.141 · Cited by 62
Zhu, W.-J., Yang, S.-D., Qu, C., Zhu, Q., Chen, W.-L., Li, F., Yuan, Z.-Q., Liu, Y., You, B., & Zhang, X. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s126310 · Cited by 62
Engineering biodegradable nanoparticles for drug and gene delivery.
Zhang, J., & Saltzman, W. M. (2013) · PubMed · Cited by 61
Wang, M., Geilich, B., Keidar, M., & Webster, T. J. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s129266 · Cited by 59
Targeting prostate cancer cells with PSMA inhibitor-guided gold nanoparticles
Kasten, B. B., Liu, T., Nedrow, J. R., Benny, P. D., & Berkman, C. E. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.11.015 · Cited by 56
Zheng, M., Zhong, Z., Zhou, L., Peng, R., Peng, R., & Zhong, Z. (2012) · Biomacromolecules · doi:10.1021/bm2017965 · Cited by 54
pH-triggered degradable polymeric micelles for targeted anti-tumor drug delivery
Qiu, L., Zhu, M., Gong, K., Peng, H., Ge, L., Zhao, L., & Chen, J. (2017) · Materials Science and Engineering C · doi:10.1016/j.msec.2017.04.137 · Cited by 54
Wang, H., Tam, Y. Y. C., Chen, S., Zaifman, J., van der Meel, R., Ciufolini, M. A., & Cullis, P. R. (2016) · Molecular Therapy · doi:10.1038/mt.2016.179 · Cited by 50
Shih, Y., Luo, T., Chiang, P.-F., Yao, C.-J., Lin, W., Peng, C., & Shieh, M. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.04.031 · Cited by 50
Nanoparticles in Drug Delivery and Cancer Therapy: The Giant Rats Tail
Prabhu, V., Uzzaman, S., Grace, V. M. B., & Guruvayoorappan, C. (2011) · Journal of Cancer Therapy · doi:10.4236/jct.2011.23045 · Cited by 47
In vivoanti-tumor efficacy of docetaxel-loaded thermally responsive nanohydrogel
Zhang, J., Qian, Z., & Gu, Y. (2009) · Nanotechnology · doi:10.1088/0957-4484/20/32/325102 · Cited by 46
Flak, D., Yate, L., Nowaczyk, G., & Jurga, S. (2017) · Materials Science and Engineering C · doi:10.1016/j.msec.2017.04.107 · Cited by 46
LHRH-Targeted Nanoparticles for Cancer Therapeutics
Minko, T., Patil, M. L., Zhang, M., Khandare, J. J., Saad, M., Chandna, P., & Taratula, O. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-609-2_19 · Cited by 45
Perumal, V., Banerjee, S., Das, S., Sen, R., & Mandal, M. (2011) · Cancer Nanotechnology · doi:10.1007/s12645-011-0017-5 · Cited by 45
Xie, Y., Killinger, B. A., Moszczyńska, A., & Merkel, O. M. (2016) · Molecules · doi:10.3390/molecules21101334 · Cited by 45
Redox-triggered mitoxantrone prodrug micelles for overcoming multidrug-resistant breast cancer
Qiao, H., Zhu, Z., Fang, D., Sun, Y., Chen, K., Di, L., Zhang, L., & Gao, Y. (2017) · Journal of drug targeting · doi:10.1080/1061186x.2017.1339195 · Cited by 45
Integrin targeted drug and gene delivery
Wang, Z., Chui, W., & Ho, P. C. (2010) · Expert Opinion on Drug Delivery · doi:10.1517/17425240903468696 · Cited by 39
First-Line Chemotherapy for Metastatic Breast Cancer
Telli, M. L., & Carlson, R. W. (2009) · Clinical Breast Cancer · doi:10.3816/cbc.2009.s.007 · Cited by 38
Preparation, characterization, and efficacy of thermosensitive liposomes containing paclitaxel
Wang, Z., Zhang, H., Yang, Y., Xie, X., Yang, Y., Li, Z., Li, Y., Gong, W., Yu, F., Yang, Z., et al. (2015) · Drug Delivery · doi:10.3109/10717544.2015.1122674 · Cited by 38
Nanoparticle delivery of an AKT/PDK1 inhibitor improves the therapeutic effect in pancreatic cancer
Pagel, M. D., Jeffery, J. J., Abril, E. R., Nagle, R. B., Guzman, R. Z., Meuillet, E. J., & Lucero‐Acuña, A. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s68511 · Cited by 35
Sardo, C., Bassi, B., Craparo, E. F., Scialabba, C., Cabrini, E., Dacarro, G., D’Agostino, A., Taglietti, A., Giammona, G., Pallavicini, P., et al. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.01.022 · Cited by 34
Targeted Nanoparticulate drug-delivery Systems for Treatment of Solid Tumors: a Review
Bhattacharjee, H., Balabathula, P., & Wood, G. C. (2010) · Therapeutic Delivery · doi:10.4155/tde.10.47 · Cited by 32
Nie, X., Zhang, J., Xu, Q., Liu, X., Li, Y., Wu, Y. F., & Chen, C. (2014) · Journal of Materials Chemistry B · doi:10.1039/c3tb21744b · Cited by 32
Zhang, X., Liu, N., Shao, Z., Qiu, H., Yao, H., Ji, J., Wang, J., Lu, W., Chen, R. C., & Zhang, L. (2017) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2017.01.015 · Cited by 32
Synthetic vehicles for DNA vaccination
van den Berg, J. H., Nuijen, B., Schumacher, T. N., Haanen, J. B. A. G., Storm, G., Beijnen, J. H., & Hennink, W. E. (2009) · Journal of drug targeting · doi:10.3109/10611860903278023 · Cited by 31
IL-24 modulates the high mobility group (HMG) A1/miR222 /AKT signaling in lung cancer cells
Panneerselvam, J., Srivastava, A., Muralidharan, R., Wang, Q., Zheng, W., Zhao, L., Chen, A., Zhao, Y. D., Munshi, A., & Ramesh, R. (2016) · Oncotarget · doi:10.18632/oncotarget.11838 · Cited by 31
Chemotherapy beyond first-line in stage IV metastatic non-small cell lung cancer
Younes, R. N., Pereira, J. R., Fares, A. L., & Gross, J. (2011) · Revista da Associação Médica Brasileira · doi:10.1590/s0104-42302011000600017 · Cited by 23
Yoshida, T., Tokashiki, R., Ito, H., et al. (2008) · Auris Nasus Larynx · doi:10.1016/j.anl.2007.10.008 · Cited by 22
Kulsharova, G., Lee, M. B., Cheng, F., Haque, M., Choi, H., Kim, K., O’Brien, W. D., & Liu, G. L. (2013) · IEEE Transactions on NanoBioscience · doi:10.1109/tnb.2013.2274781 · Cited by 20
Morabito, A., Piccirillo, M. C., Monaco, K., Pacilio, C., Nuzzo, F., Chiodini, P., Gallo, C., Matteis, A. D., Perrone, F., & for the NCI Naples Breast Cancer Group (2007) · The Oncologist · doi:10.1634/theoncologist.12-11-1288 · Cited by 13
Mohammad, F., & Al‐Lohedan, H. A. (2017) · Materials Science and Engineering C · doi:10.1016/j.msec.2017.03.162 · Cited by 11
Novel siRNA formulation to effectively knockdown mutant p53 in osteosarcoma
Kundu, A. K., Iyer, S. V., Chandra, S., Adhikari, A. S., Iwakuma, T., & Mandal, T. K. (2017) · PLoS ONE · doi:10.1371/journal.pone.0179168 · Cited by 11
Gene Silencing Therapy Against Cancer
Song, C.-Z. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-222-9_11 · Cited by 10
Burrer, C. M., Auburn, H., Wang, X., Luo, J., Abulwerdi, F. A., Nikolovska‐Coleska, Z., & Chan, G. C. T. (2016) · Antiviral Research · doi:10.1016/j.antiviral.2016.11.027 · Cited by 4
Cited by
Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance
Yao, Y., Zhou, Y., Liu, L., Xu, Y., Chen, Q., Wang, Y., Wu, S., Deng, Y., Zhang, J., & Shao, A. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.00193 · Cited by 1,451
Nanoparticles for Cancer Therapy: Current Progress and Challenges
Gavas, S., Quazi, S., & Karpiński, T. M. (2021) · Nanoscale Research Letters · doi:10.1186/s11671-021-03628-6 · Cited by 1,069
Li, F.-J., Long, H.-Z., Zhou, Z.-W., Luo, H.-Y., Xu, S.-G., & Gao, L.-C. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.910292 · Cited by 438
Hetta, H. F., Ramadan, Y. N., Al-Harbi, A. I., A. Ahmed, E., Battah, B., Abd Ellah, N. H., Zanetti, S., & Donadu, M. G. (2023) · Biomedicines · doi:10.3390/biomedicines11020413 · Cited by 333
Nanoparticle–hydrogel superstructures for biomedical applications
Jiang, Y., Krishnan, N., Heo, J., Fang, R. H., & Zhang, L. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.05.041 · Cited by 266
Metadata
- Venue
- Advances in Cancer Research
- Publisher
- Elsevier
- Published
- 2018
- Volume
- 137
- Pages
- 115-170
- ISSN
- 0065-230X (ISSN-L)
- OpenAlex
- W2774577787
- Cited by
- 288
- References
- 185
- FWCI
- 11.14
- Type
- book chapter
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.